Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence*

Authors


  • *

    This study was performed at the Norwegian School of Veterinary Sciences, Ullevalsveien 72 Postboks 8146 Dep, 0033 Oslo, Norway and Centro de Especialistas Veterinarios de Puerto Rico, RR16 #3250 San Juan, Puerto Rico 00926.

K. U. Sorenmo
Department of Clinical studies Veterinary Hospital of the University of Pennsylvania, 3900 Delancey Street
Philadelphia PA 19104
e-mail: karins@vet.upenn.edu

Abstract

This study describes the clinical and histopathological findings in dogs with mammary gland tumours, and compares the histopathological and clinical evidence consistent with progression from benign to malignant to human breast cancer epidemiology. Clinical and histopathological data on 90 female dogs with 236 tumours was included. Dogs with malignant tumours were significantly older than dogs with benign tumours (9.5 versus 8.5 years), P = 0.009. Malignant tumours were significantly larger than benign tumours (4.7 versus 2.1 cm), P = 0.0002. Sixty-six percent had more than one tumour, and evidence of histological progression was noted with increasing tumour size. Dogs with malignant tumours were significantly more likely to develop new primary tumours than dogs with benign tumours, P = 0.015. These findings suggest that canine mammary tumours progress from benign to malignant; malignant tumours may be the end stage of a histological continuum with clinical and histopathological similarities to human breast carcinogenesis.

Ancillary